Navigating the world is no mean feat, especially when the world pushes back. For instance, airflow hitting a fly on its right ...
CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved for the treatment of patients with multiple myeloma who have had at least one prior line of therapy. Globally, CARVYKTI ® is ...
A research team led by the University of Oxford's Department of Engineering Science has shown it is possible to engineer a ...